Aminophylline Prophylaxis For Postdural Puncture Headache

postdural puncture headache is a rare but serious complication of spinal anesthesia. many drugs were studied in prevention or treatment of that complication. However, there are limited numbers of trials about intravenous aminophylline for prevention. because of that we retrospectively aimed to investigate the effectiveness of aminophylline for postdural puncture headache in cesarean section.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postdural Puncture Headache Brain Diseases Central Nervous System Diseases Headache Disorders Headache Disorders, Secondary Nervous System Diseases Post-Dural Puncture Headache

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Dışkapı Yıldırım Beyazıt Education and Research Hospital

Ankara, 06110, Turkey (Türkiye)

About this study

retrospective trial about the effect of intravenous aminophylline for prevention of PDPH after caserean section with spinal anesthesia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients aolder than 18 years old

Exclusion criteria

conversion to general anesthesia

Treatment and study plan

Primary outcomes

postdural puncture headache

Time frame: postoperative 2 weeks

Sponsors and collaborators

Lead sponsor

Diskapi Yildirim Beyazit Education and Research Hospital

Other Gov

Registry information

Official study title

Phase IV Study of Intravenous Aminophylline During Spinal Anesthesia

Important dates

Study start: 2014
Primary completion: 2014
Study completion: 2014
First posted: May 29, 2014
Registry last updated: Aug 5, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed